N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol
C78H89F8N25O7S3 — CID 158054111
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol
N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol (PubChem CID 158054111) has the molecular formula C78H89F8N25O7S3 and a molecular weight of 1736.92 g/mol. Its IUPAC name is N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol.
Molecular Properties
| Compound Name | N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol |
|---|---|
| PubChem CID | 158054111 |
| Molecular Formula | C78H89F8N25O7S3 |
| Molecular Weight | 1736.92 g/mol |
| Exact Mass | 1735.64 |
| IUPAC Name | N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-6-(methylamino)-2-pyridinyl]piperidin-3-yl]methyl]methanesulfonamide;N-[[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]-3-methylpiperidin-3-yl]methyl]methanesulfonamide;N-[2-[1-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]piperidin-3-yl]propan-2-yl]methanesulfonamide;2-[4-[4-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridinyl]pyrazol-1-yl]ethanol |
| SMILES | CC(C)(NS(C)(=O)=O)C1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ccn2)C1.CC1(CNS(C)(=O)=O)CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ccn2)C1.CNc1cc(-c2cnc3ccc(C(F)F)nn23)cc(N2CCCC(CNS(C)(=O)=O)C2)n1.OCCn1cc(-c2cc(-c3cnc4ccc(C(F)F)nn34)ccn2)cn1 |
| InChI | InChI=1S/C21H26F2N6O2S.C20H25F2N7O2S.C20H24F2N6O2S.C17H14F2N6O/c1-21(2,27-32(3,30)31)15-5-4-10-28(13-15)19-11-14(8-9-24-19)17-12-25-18-7-6-16(20(22)23)26-29(17)18;1-23-17-8-14(16-11-24-18-6-5-15(20(21)22)27-29(16)18)9-19(26-17)28-7-3-4-13(12-28)10-25-32(2,30)31;1-20(12-25-31(2,29)30)7-3-9-27(13-20)18-10-14(6-8-23-18)16-11-24-17-5-4-15(19(21)22)26-28(16)17;18-17(19)13-1-2-16-21-9-15(25(16)23-13)11-3-4-20-14(7-11)12-8-22-24(10-12)5-6-26/h6-9,11-12,15,20,27H,4-5,10,13H2,1-3H3;5-6,8-9,11,13,20,25H,3-4,7,10,12H2,1-2H3,(H,23,26);4-6,8,10-11,19,25H,3,7,9,12-13H2,1-2H3;1-4,7-10,17,26H,5-6H2 |
| InChIKey | FJVJLFHJABWWCV-UHFFFAOYSA-N |
| XLogP | 11.28 |
| TPSA | 370.63 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 121 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1736.92 |
| LogP ≤ 5 | 11.28 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 29 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158054111 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.